Childhood medulloblastoma: progress and future challenges (Q33595763)

28 July 2017

1 reference

title

Childhood medulloblastoma: progress and future challenges (English)

1 reference

childhood medulloblastoma

28 July 2017

0 references

1 reference

Packer RJ

1

1 reference

28 July 2017

language of work or name

1 reference

1 March 1999

1 reference

28 July 2017

published in

Brain and Development

1 reference

28 July 2017

volume

21

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

75-81

1 reference

Management of children with primitive neuroectodermal tumors of the posterior fossa/medulloblastoma

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2898%2900085-0

7 January 2021

Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2898%2900085-0

7 January 2021

A prospective study of cognitive function in children receiving whole-brain radiotherapy and chemotherapy: 2-year results.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2898%2900085-0

7 January 2021

Medulloblastoma and other primary malignant neuroectodermal tumors of the CNS. The effect of patients' age and extent of disease on prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2898%2900085-0

7 January 2021

Myelography and cytology in the treatment of medulloblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2898%2900085-0

7 January 2021

The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2898%2900085-0

7 January 2021

Effects of medulloblastoma resections on outcome in children: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2898%2900085-0

7 January 2021

Survival and prognostic factors following radiation and/or chemotherapy for primitive neuroectodermal tumors of the pineal region in infants and children: a report of the Childrens Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2898%2900085-0

7 January 2021

Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: a Childrens Cancer Group randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2898%2900085-0

7 January 2021

Isochromosome 17q demonstrated by interphase fluorescence in situ hybridization in primitive neuroectodermal tumors of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2898%2900085-0

7 January 2021

Tumor suppressor genes and medulloblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2898%2900085-0

7 January 2021

Prognostic importance of cellular differentiation in medulloblastoma of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2898%2900085-0

7 January 2021

Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2898%2900085-0

7 January 2021

Prognostic factors in medulloblastoma, including DNA ploidy

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2898%2900085-0

7 January 2021

Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2898%2900085-0

7 January 2021

Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 cGy/13) in patients with low-stage medulloblastoma. A Combined Children's Cancer Group-Pediatric Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2898%2900085-0

7 January 2021

Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2898%2900085-0

7 January 2021

Pre-irradiation chemotherapy for infants and children with medulloblastoma: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2898%2900085-0

7 January 2021

Carboplatin in childhood medulloblastoma/PNET: feasibility of an in vivo sensitivity test in an "up-front" study.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2898%2900085-0

7 January 2021

Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2898%2900085-0

7 January 2021

Survival and neurologic outcome of infants with medulloblastoma treated with surgery and MOPP chemotherapy. A preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2898%2900085-0

7 January 2021

Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2898%2900085-0

7 January 2021

Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2898%2900085-0

7 January 2021

Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0387-7604%2898%2900085-0

7 January 2021

10.1016/S0387-7604(98)00085-0

Identifiers

DOI

1 reference

28 July 2017

1 reference